The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 new drug formulations including those ...

Metformin costs about five cents a pill. More than 150 million people worldwide swallow it every day to manage type 2 ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

Diabetes and Parkinson’s patients are facing drug shortages because of the Iran war, pharmacists have warned. Shortages of several critical medicines have become “considerably worse” over the past two ...

Ozempic has become one of the most talked-about diabetes medications in the world, especially as more adults ask about blood ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

Cases of diabetes in Wales are climbing faster than projected, new NHS data has revealed. The number of people with diabetes ...

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

A former USPS mail carrier was sentenced in Boston after prosecutors said he stole prescription medications from customers on his route.

Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer ...